FDA authorized marketing of first diagnostic test for detecting Zika virus antibodies
On May 23, 2019, the U.S. Food and Drug Administration (FDA) announced that it had authorized InBios’ marketing…
Chembio Diagnostics received approval of Zika, Dengue and Chikungunya point-of-care multiplex test by Brazil’s Health Regulatory Agency
On Apr. 9, 2019, Chembio Diagnostics announced the approval of its DPP Zika/Dengue/Chikungunya System by Agencia Nacional de…
Diagnostics | Disease | FDA
InBios received FDA clearance for its DENV detect NS1 ELISA test for early detection of Dengue fever
On Sept. 11, 2018, the U.S. Food and Drug Administration (FDA) had announced that it had received 510k…
AbCellera raises $10M for machine-learning fueled antibody discovery platform
On Sept. 27, 2018, AbCellera, a biotech startup based in Vancouver, B.C., announced that it has raised a…
InBios received FDA EUA for its ZIKV Detect IgM Capture ELISA diagnostic test for antibodies in human serum
On Aug. 19, 2016, InBios announced that it had received an Emergency Use Authorization (EUA) from the U.S….
InBios received USDA license for its West Nile Virus antibody detection kit for horses
On Jan. 24, 2014, InBios announced that it had licensed a U.S. Department of Agriculture (USDA) West Nile…
Sanford Health acquired Hematech
On Jan. 4, 2013, Sanford Health announced the acquisition of Sioux Falls-based biotech company Hematech, a subsidiary of…
Drs. Judith James and John Harley at the OMRF published an important study that showed certain antibodies for lupus were typically present years before the disease with diagnosed
On Oct. 16, 2003, scientists from the Oklahoma Medical Research Foundation (OMRF) and the University of Oklahoma Health…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics | Women's Health
The FDA approved the monoclonal antibody Herceptin (Trastuzumab) for treatment of metastatic breast cancer
On Sept. 25, 1998, the U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Herceptin (Trastuzumab) for…
Aptein was acquired by Cambridge Antibody Technology
On Jul. 15, 1998, Aptein, founded by Glenn Kawasaki in Seattle, was acquired by Cambridge Antibody Technology (CAT)…
Hematech relocated to Sioux Falls
In 1998, Hematech was co-founded by University of Massachusetts researcher Jim Robl, relocated to Sioux Falls. Dr. Robl…
Diagnostics | FDA | HIV
The FDA approved the first test for HIV antigen screening of blood donors
On Mar. 14, 1996, the U.S. Food and Drug Administration (FDA) announced the approval of the first antigen…
Gene therapy, immune-system modulation and recombinantly produced antibodies entered the clinic in the war against cancer
In 1995, Gene therapy, immune-system modulation and recombinantly produced antibodies enter the clinic in the war against cancer….
The FDA approved the first US HIV test system using oral fluid samples
On Dec. 23, 1994, the FDA announced the approval of the first U.S. HIV test system using oral…
Testing of donor blood was implemented for HIV-1 and HIV-2 antibodies (anti-HIV-1 and anti-HIV-2)
On Jun. 1, 1992, the FDA recommended that all donated blood be screened for antibodies to human immunodeficiency…
UC San Diego Alumnus Susumu Tonegawa was awarded the Nobel Prize for Physiology or Medicine
In 1987, University of California, San Diego Alumnus Susumu Tonegawa was awarded he Nobel Prize for Physiology or…
Eli Lilly acquired Hybritech
On Mar. 19, 1986, Eli Lilly acquired San Diego-based Hybritech for $300 million. Hybritech was a leading producer…
FDA approved Hybritech antibody test for prostate cancer – a first
In February 1986, the U.S. Food and Drug Administration (FDA) approved Hybritech’s Tandem-R PSA assay (P850048) with calibration…
Dr. Tak Wah Mak co-discovered the T-cell receptor and the gene that produces it
In 1983, Dr. Tak Wah Mak co-discovered the T-cell receptor and the gene that produces it. Dr. Mak…
Stanford Medicine researchers first reported successful use of monoclonal antibodies to treat cancer
In 1981, Stanford oncologist Ronald Levy reported the first successful use of monoclonal antibodies, which are laboratory-created molecules…
Hybritech issued its Initial Public Offering
In 1981, Hybritech issued its Initial Public Offering (IPO) and raised $12 million, and $33 million in a…
Biotechnology | Disease | FDA | Therapeutics
Imre Corp was founded
In 1981, Imre Corp. (Immune Response Systems, Inc.) was founded in Seattle. The company developed the Prosorba Column,…
Stanford Medicine researchers first created a human hybridoma cell line
On Nov. 7, 1980, Stanford University researchers Henry Kaplan and Lennart Olsson announced they had created cells to…
Genetic Systems was founded
In 1980, Genetic Systems was founded in Seattle as a monoclonal antibody-based diagnostic company by Robert Nowinski of…
Hybritech was founded in San Diego
In 1978, Hybritech was founded by cancer researcher Ivor Royston and lab technician Howard Birndorf of the University…
Monoclonal antibodies first produced by Georges Kohler and Cesar Milstein
In 1975, Georges Kohler and Cesar Milstein, showed how monoclonal antibodies can be generated by isolating individual fused…
Gerald Maurice Edelman was awarded Nobel Prize in Medicine
In October 1972, Gerald Maurice Edelman (M.D., University of Pennsylvania, 1954) was was awarded the 1972 Nobel Prize…
Vancomycin was isolated by Dr. E.C. Kornfield
In 1957, vancomycin was isolated by Dr. E.C. Kornfield, an organic chemist with Eli Lilly in the deep…
Dr. William Hammon published first evidence that antibodies to polio could prevent disease
In Oct. 1952, Dr. William McDowall Hammon of the University of Pittsburgh Graduate School of Public Health published…
Dr. Jonas Salk began taking blood samples from recently paralyzed polio patients to determine antibody types
On Jun. 12, 1952, Dr. Jonas Salk went to the D. T. Watson Home for Crippled Children (now…